… Study Rationale:  Chronic exposure to environmental contaminants is believed to play an … PD-associated environmental exposures. Once these molecules enter the bloodstream, they may affect blood vessels prior … brain chips will be treated with a selection of chemical compounds or physiological molecules associated with PD or …

… States, including disparities affecting underrepresented communities, such as women, residents of rural areas, and … can recognize PD’s distinct nuances and tailor treatments to each patient. An additional 51 percent of Medicare … expert Parkinson’s care across the globe. Depending on where they train, some doctors and other clinicians may get …

… of 14-3-3 proteins is implicated in PD, and we have previously demonstrated that increasing 14-3-3 expression is … that affects normal function — is increased in PD brains compared to controls. This modification reduces neuroprotection by … Access to Data and Biospecimens …

… Objective/Rationale: This project aims to identify drug-like molecules that increase the amount of … of clinically approved drugs, pharmacologically active compounds isolated from natural sources, and diverse … effects. We will then test the most optimal molecules in pre-clinical models to demonstrate their benefit. This …

… proven safe in a clinical trial for a certain indication, to determine whether the drug might be efficacious in the … for PD.  MJFF also supported a team investigating if a compound used to treat Attention Deficit Hyperactivity … endpoints in clinical studies. Of course, later trials showed that it could work for erectile dysfunction. And then, …

… for PD, either in the United States or the international community, meaning scientists need to put significant resources into estimating the number of cases. That’s partially why a study published in The BMJ in … estimate of total number of cases by a given year. This is compounded by a number of other factors that influence …